Today's Information

Provided by: Center Laboratories, Inc.
SEQ_NO 3 Date of announcement 2022/05/20 Time of announcement 20:42:55
Subject
 Announcement of the appointment of representative
by the newly elected institutional director
Date of events 2022/05/20 To which item it meets paragraph 6
Statement
1.Date of occurrence of the change:2022/05/20
2.Name of legal person:
(1)Lejean Biotech Co., Ltd.
(2)Wechen Co. Ltd.
(3)Po Chang Investment Co., Ltd.
3.Name of the previous position holder:
(1)LeJean Biotech Co., Ltd. appointed Lin, Chia-Ling to present .
(2)Wechen Co. Ltd. appointed Tsai, Pei-Chen to present.
(3)Po Chang Investment Co., Ltd. appointed Chen, Chun-Hong to present.
4.Resume of the previous position holder:
(1)Lin, Chia-Ling:Director of Mycenax Biotech Inc.
(2)Tsai, Pei-Chen:Director of Center Laboratories, Inc.
(3)Chen, Chun-Hong:Chairman of MasterLink Securities Corporation.
5.Name of the new position holder:
(1)LeJean Biotech Co., Ltd. appointed Lin, Chia-Ling to present.
(2)Wechen Co. Ltd. appointed Tsai, Pei-Chen to present.
(3)Po Chang Investment Co., Ltd. appointed Chen, Chun-Hong to present.
6.Resume of the new position holder:
(1)Lin, Chia-Ling:Director of Mycenax Biotech Inc.
(2)Tsai, Pei-Chen:Director of Center Laboratories, Inc.
(3)Chen, Chun-Hong:Chairman of MasterLink Securities Corporation.
7.Reason for the change:
Re-election of Board of Directors, the newly elected institutional
director appointed representative.
8.Original term (from __________ to __________):
2019/06/24~2022/06/23
9.Effective date of the new appointment:2022/05/20
10.Any other matters that need to be specified:None.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Center Laboratories Inc. published this content on 20 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2022 12:44:03 UTC.